BridgeBio Pharma 株価情報 (NASDAQ: BBIO)

BridgeBio Pharma (NASDAQ:BBIO) 株価情報

BridgeBio Pharma

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

BridgeBio Pharma Inc

UBS analyst Taylor McGinnis maintains Procore Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PCOR#NYSE">PCOR</a>) with a Buy and lowers the price target from $110 to $87.

News

Price Target

Analyst Ratings

PCOR

UBS Maintains Buy on Procore Technologies, Lowers Price Target to $87

UBS analyst Josh Silverstein maintains Range Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RRC#NYSE">RRC</a>) with a Neutral and raises the price target from $36 to $37.

UBS Maintains Neutral on Range Resources, Raises Price Target to $37

<h3>Gainers</h3>
<ul>
<li>Arena Group Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AREN#AMEX">AREN</a>) stock moved upwards by 24.1% to $4.17 during Thursday's regular session. The company's market cap stands at $198.3 million. </li>
<li>TEN Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XHLD#NASDAQ">XHLD</a>) stock rose 20.13% to $0.88. The company's market cap stands at $24.7 million. </li>
<li>WiMi Hologram Cloud (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WIMI#NASDAQ">WIMI</a>) shares rose 17.24% to $5.78. The company's market cap stands at $56.7 million. </li>
<li>EPWK Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EPWK#NASDAQ">EPWK</a>) shares increased by 15.64% to $9.39. The company's market cap stands at $209.5 million. </li>
<li>Anghami (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGH#NASDAQ">ANGH</a>) shares increased by 14.49% to $0.64. The company's market cap stands at $42.7 million. </li>
<li>Surgepays (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SURG#NASDAQ">SURG</a>) stock rose 13.45% to $2.98. The company's market cap stands at $60.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>TNL Mediagene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNMG#NASDAQ">TNMG</a>) stock decreased by 16.9% to $0.29 during Thursday's regular session. The market value of their outstanding shares is at $7.6 million. </li>
<li>Cumulus Media (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMLS#NASDAQ">CMLS</a>) stock fell 15.12% to $0.23. The company's market cap stands at $3.8 million. </li>
<li>LQR House (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YHC#NASDAQ">YHC</a>) shares decreased by 10.74% to $2.54. The company's market cap stands at $1.6 million. </li>
<li>TruGolf Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUG#NASDAQ">TRUG</a>) stock fell 9.48% to $0.3. The market value of their outstanding shares is at $9.3 million. </li>
<li>Reading Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDIB#NASDAQ">RDIB</a>) shares fell 8.01% to $9.58. The market value of their outstanding shares is at $214.7 million. </li>
<li>iOThree (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOTR#NASDAQ">IOTR</a>) stock declined by 7.22% to $0.9. The company's market cap stands at $23.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ANGH

AREN

CMLS

EPWK

IOTR

RDIB

SURG

TNMG

TRUG

WIMI

XHLD

12 Communication Services Stocks Moving In Thursday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>CERo Therapeutics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERO#NASDAQ">CERO</a>) stock moved upwards by 37.6% to $1.1 during Thursday's regular session. The company's market cap stands at $5.9 million. </li>
<li>TransCode Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) shares increased by 26.43% to $0.4. The market value of their outstanding shares is at $9.2 million. </li>
<li>Zhengye Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYBT#NASDAQ">ZYBT</a>) shares increased by 24.8% to $9.76. The market value of their outstanding shares is at $462.5 million. </li>
<li>Community Health Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) shares increased by 24.69% to $3.03. The market value of their outstanding shares is at $420.9 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>BioSig Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSGM#NASDAQ">BSGM</a>) shares increased by 23.43% to $0.79. The market value of their outstanding shares is at $19.1 million. </li>
<li>Jaguar Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAGX#NASDAQ">JAGX</a>) shares moved upwards by 19.94% to $8.0. The market value of their outstanding shares is at $5.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>NuCana (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNA#NASDAQ">NCNA</a>) shares decreased by 26.3% to $0.66 during Thursday's regular session. The company's market cap stands at $3.9 million. </li>
<li>Intensity Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTS#NASDAQ">INTS</a>) shares decreased by 23.85% to $0.99. The company's market cap stands at $15.0 million. </li>
<li>Ensysce Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSC#NASDAQ">ENSC</a>) shares declined by 16.08% to $3.08. The company's market cap stands at $5.0 million. </li>
<li>Metsera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSR#NASDAQ">MTSR</a>) stock fell 15.17% to $20.0. The company's market cap stands at $2.1 billion. </li>
<li>Catheter Precision (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VTAK#AMEX">VTAK</a>) stock declined by 12.5% to $0.28. The market value of their outstanding shares is at $2.2 million. </li>
<li>Plus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTV#NASDAQ">PSTV</a>) shares decreased by 11.41% to $0.87. The market value of their outstanding shares is at $5.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BSGM

CERO

ENSC

INTS

JAGX

MTSR

NCNA

PSTV

RNAZ

VTAK

ZYBT

12 Health Care Stocks Moving In Thursday's Intraday Session

Morgan Stanley analyst Michael Ulz maintains Viking Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VKTX#NASDAQ">VKTX</a>) with a Overweight and lowers the price target from $105 to $102.

VKTX

Morgan Stanley Maintains Overweight on Viking Therapeutics, Lowers Price Target to $102

UBS analyst David Vogt maintains IBM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) with a Sell and raises the price target from $160 to $170.

UBS Maintains Sell on IBM, Raises Price Target to $170

<h3>Gainers</h3>
<ul>
<li>Odyssey Marine Explr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMEX#NASDAQ">OMEX</a>) stock rose 99.6% to $0.85 during Thursday's regular session. The market value of their outstanding shares is at $24.7 million. </li>
<li>American Rebel Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AREB#NASDAQ">AREB</a>) shares increased by 34.03% to $4.12. The company's market cap stands at $9.7 million. </li>
<li>Energys Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENGS#NASDAQ">ENGS</a>) stock increased by 26.24% to $9.24. The company's market cap stands at $131.6 million. </li>
<li>Elong Power Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELPW#NASDAQ">ELPW</a>) stock rose 21.37% to $3.27. The company's market cap stands at $163.4 million. </li>
<li>Shyft Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHYF#NASDAQ">SHYF</a>) shares increased by 19.58% to $8.73. The company's market cap stands at $304.9 million. As per the press release, Q1 earnings came out today. </li>
<li>Nauticus Robotics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KITT#NASDAQ">KITT</a>) shares rose 16.63% to $1.13. The company's market cap stands at $39.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Azul (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZUL#NYSE">AZUL</a>) shares fell 19.4% to $1.25 during Thursday's regular session. The company's market cap stands at $191.6 million. </li>
<li>Jayud Global Logistics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JYD#NASDAQ">JYD</a>) stock fell 17.97% to $0.22. The company's market cap stands at $20.7 million. </li>
<li>CBIZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBZ#NYSE">CBZ</a>) stock decreased by 12.12% to $67.88. The market value of their outstanding shares is at $3.4 billion. As per the news, the Q1 earnings report came out today. </li>
<li>Apogee Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APOG#NASDAQ">APOG</a>) stock fell 9.72% to $41.46. The company's market cap stands at $910.1 million. As per the news, the Q4 earnings report came out today. </li>
<li>FBS Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBGL#NASDAQ">FBGL</a>) shares fell 9.02% to $0.67. The company's market cap stands at $9.0 million. </li>
<li>Alaska Air Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALK#NYSE">ALK</a>) shares decreased by 8.98% to $41.97. The company's market cap stands at $5.1 billion. As per the news, the Q1 earnings report came out yesterday. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

APOG

AREB

AZUL

ELPW

ENGS

FBGL

KITT

OMEX

SHYF

12 Industrials Stocks Moving In Thursday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Pony AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>) shares moved upwards by 30.3% to $7.08 during Thursday's regular session. The company's market cap stands at $2.4 billion. </li>
<li>Wolfspeed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) shares increased by 19.88% to $3.08. The company's market cap stands at $479.3 million. </li>
<li>SMX (Security Matters) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMX#NASDAQ">SMX</a>) stock increased by 18.27% to $2.2. The company's market cap stands at $2.5 million. </li>
<li>ZenaTech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZENA#NASDAQ">ZENA</a>) stock moved upwards by 18.26% to $2.59. The company's market cap stands at $45.7 million. </li>
<li>Orangekloud Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORKT#NASDAQ">ORKT</a>) stock increased by 17.89% to $0.66. The company's market cap stands at $15.2 million. </li>
<li>Tungray Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRSG#NASDAQ">TRSG</a>) shares rose 17.88% to $1.78. The market value of their outstanding shares is at $29.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Marin Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) shares declined by 16.1% to $0.54 during Thursday's regular session. The company's market cap stands at $1.6 million. </li>
<li>Wetouch Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WETH#NASDAQ">WETH</a>) stock declined by 16.04% to $0.89. The market value of their outstanding shares is at $10.6 million. </li>
<li>Yxt.Com Group Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YXT#NASDAQ">YXT</a>) shares decreased by 15.79% to $0.56. The company's market cap stands at $33.3 million. </li>
<li>MaxLinear (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MXL#NASDAQ">MXL</a>) shares declined by 15.72% to $9.28. The company's market cap stands at $785.3 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>ASGN (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASGN#NYSE">ASGN</a>) stock declined by 14.57% to $50.02. The market value of their outstanding shares is at $2.2 billion. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Bit Origin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTOG#NASDAQ">BTOG</a>) shares fell 12.52% to $0.15. The company's market cap stands at $1.2 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ASGN

BTOG

MRIN

ORKT

PONY

TRSG

WETH

WOLF

ZENA

12 Information Technology Stocks Moving In Thursday's Intraday Session

Morgan Stanley analyst Chris Snyder maintains Vertiv Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRT#NYSE">VRT</a>) with a Overweight and lowers the price target from $140 to $125.

Morgan Stanley Maintains Overweight on Vertiv Holdings, Lowers Price Target to $125

The windfall from an inheritance can lead to promising opportunities or offer a fresh start for someone who is deep in debt. However, if you don't know how to use an inheritance correctly, you can end up losing the funds.&nbsp;
It's always great to get an inheritance, but it requires a lot of responsibility to manage the money and allow it to grow over time. That's why a 23-year-old turned to Reddit after <a href="https://www.reddit.com/r/dividends/comments/1jze3zz/50k_inheritance_23_years_old_how_should_i_invest/">receiving a $50,000 inheritance</a>.&nbsp;
"How should I invest it?" the Redditor asked.
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
</ul>
The individual wants to know the best ways to invest the money and intends to let it compound for at least 10 years. Fellow Redditors jumped into the comments to offer their suggestions.
<h2 class="wp-block-heading">Start With A High-Yield Savings Account</h2>
One commenter suggested that the Redditor put the money into a high-yield savings account. Some of these accounts yield more than 4% APY, and if you look for online banks, it gets even easier to find that type of yield.
These accounts come with no risk since you cannot lose principal. However, these accounts can underperform inflation, and you might miss out on better investing opportunities. Furthermore, interest income is treated as ordinary income, so the real return on your savings account will be less than the posted APY.&nbsp;
While the 23-year-old might earn higher returns with an index fund, a high-yield savings account gives them time to think about where to put the money. If you ask Reddit about what to do with a $50,000 inheritance, you shouldn't rush to make a decision. While there was great advice, it's best to take things slowly when you receive a significant windfall and don't have much investing experience.&nbsp;
Trending: The secret weapon in billionaire investor portfolios that you almost certainly don't own yet. <a href="https://www.benzinga.com/money/masterworks">See which asset class has outpaced the S&amp;P 500 (1995-2024) – and with near-zero correlation.</a>
<h2 class="wp-block-heading">Regularly Contribute To A Roth IRA</h2>
The same Redditor who suggested a high-yield savings account also recommended contributing to a Roth IRA. The 23-year-old has enough money to contribute to a Roth IRA for the next seven years thanks to the inheritance.&nbsp;
Granted, the Redditor can contribute some of their own paychecks into a Roth IRA and put the inheritance money in a brokerage account. This approach, if the Redditor believes it's right for them, would allow the individual to invest more than $7,000 per year.
The main advantage of a Roth IRA is that the dividends and capital gains are all tax-free. You can't withdraw until you turn 59 1/2 years old, but you can gradually build your Roth IRA over time.
See Also: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.
<h2 class="wp-block-heading">Diversify Into ETFs</h2>
Multiple commenters suggested that the Redditor spreads the inheritance across ETFs. Since this is the Dividends subreddit, most of the commenters suggested high-yield dividend ETFs.
Some Redditors also suggested business development companies and real estate investment trusts, two asset classes that are known for their high yields. Keeping these assets in a Roth IRA will allow the 23-year-old to collect cash distributions without having to pay any taxes on them.
ETFs make it much easier to invest in stocks. These funds highlight their objectives and often spread their capital across hundreds of holdings. When comparing ETFs, make sure you find funds with low expense ratios that align with your long-term goals.&nbsp;
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
</ul>
Image: Shutterstock

Personal Finance

23-Year-Old Received $50,000 Inheritance And Turns To Reddit For Advice 'How Should I Invest It?'

UBS analyst Michael Lasser maintains O'Reilly Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORLY#NASDAQ">ORLY</a>) with a Buy and raises the price target from $1535 to $1580.

ORLY

UBS Maintains Buy on O'Reilly Automotive, Raises Price Target to $1580

Morgan Stanley maintains Valero Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLO#NYSE">VLO</a>) with a Overweight and lowers the price target from $160 to $145.

Morgan Stanley Maintains Overweight on Valero Energy, Lowers Price Target to $145

UBS analyst Gavin Parsons maintains Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) with a Buy and raises the price target from $190 to $207.

UBS Maintains Buy on Boeing, Raises Price Target to $207

Morgan Stanley analyst Michael Cyprys maintains Virtu Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRT#NASDAQ">VIRT</a>) with a Underweight and raises the price target from $26 to $28.

VIRT

Morgan Stanley Maintains Underweight on Virtu Finl, Raises Price Target to $28

The average tariff rate on Chinese goods entering the United States is currently over 145%, far higher than anything President <a href="https://www.benzinga.com/topic/donald-trump">Donald Trump</a> introduced during his first term and a rate that already has severe economic effects.
While many companies opened their pocketbooks to stock up on extra merchandise to avoid tariffs, those stockpiles will dwindle in a few months, and consumers will feel the brunt of the added costs. Apparel manufacturers and retailers that source large portions of their products from China or other Asian countries will be most affected.
With tight margins, passing on costs to consumers or moving production back to the U.S. is not an option for most of them. 
Here are the four big-brand apparel companies that will be worst hit &#8211; investors beware.
<h2 class="wp-block-heading">V.F. Corp.&nbsp;</h2>
VF Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VFC#NYSE">VFC</a>) cut its dividend by 71% during an October 2023 earnings release, but that was just the tip of the iceberg for the apparel manufacturer that claims popular brands like Timberland, Vans, North Face, JanSport, and Dickie's. The stock was trading near $90 per share in the spring of 2021 and suffered a stunning decline over the next three years, bottoming out under $13 per share amid sales slumps and competition from cheaper online competitors. The stock was beginning to rebound from its May 2024 lows, but then the trade war hit, and shares slumped from $26 back down to under $11.
<figure class="wp-block-image"><img decoding="async" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXcBjBKW00Cvzi7K_zvvxJcFOIuERkwISPI7_MsmpYhtc-h_-rE-5QiNcM3xtnE5xRtDDObwpehiC9iFIBsvboyjTdObyILg5QrgD8Aq101I_7ylRmmZl9XERRja_Pr9YwI0qF1xqA?key=sXJ17IrwuKIuXW9LDYR8oIXq" alt="" /></figure>
VFC is not well-equipped to handle an extensive trade war, considering the bulk of its production comes from Asia. The company has over 400 factories in China and another 200 in Vietnam but fewer than 50 locations in the United States. Moving production back to the U.S. is untenable, so the VFC will need to seek out sites in nations with lower tariff rates, like India. VFC trades at 11 times forward earnings, which is on the high side for apparel manufacturers, especially considering its close competitor, PVH Corp, trades at just 5 times forward earnings. The company also has a high debt-to-equity ratio (3.42), declining revenue, and poor Benzinga Edge ratings, including a paltry 16.94 in Value. VFC may have brand value, but this is one falling knife not worth catching right now.
<h2 class="wp-block-heading">Columbia Sportswear Co.&nbsp;</h2>
Columbia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COLM#NYSE">COLM</a>) is another apparel company specializing in footwear and outerwear with a heavy manufacturing presence in Asia. Marketing mostly under its namesake flagship brand, Columbia was already losing market share as its sales primarily come through wholesale distribution to department and sporting goods stores. And while its products are sold worldwide, the primary manufacturing hubs are in China, Vietnam, Cambodia, and Taiwan. Although the company has significant operations in Japan, India, and Bangladesh, surviving a tariff war without further damage will be difficult due to declining margins and a valuation that doesn't match the fundamentals.
<figure class="wp-block-image"><img decoding="async" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXdzrGNLXgnGi5ddNDNYN55jQZFTbUpBm8E8yYxNPgrpngIuvH1JN53EyCYMs0iENlbwwKfilSLQA7X_nQIc_AL9f2XdnNCK6fDyfo6zKCFmlmgg2rUAN7bHF0NnGWfXW-FQjxFh5Q?key=sXJ17IrwuKIuXW9LDYR8oIXq" alt="" /></figure>
COLM trades at 16.5 times forward earnings, far higher than most apparel manufacturers, and a figure not supported by profit margins that have now dropped under 7%. Revenue has declined in four of the last five quarters, and the dividend yields just 1.87%. COLM also rates poorly on Benzinga Edge, including a 29.11 Momentum score and 39.30 Quality score. The stock chart matches these scores as a Death Cross (where the 50-day moving average drops below the 200-day moving average) formed earlier this month. The Relative Strength Index (RSI) is still above the oversold threshold at 37, indicating that the stock may still have room to drop.
<h2 class="wp-block-heading">American Eagle Outfitters Inc.&nbsp;</h2>
American Eagle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEO#NYSE">AEO</a>) used to be a staple in every suburban mall, but now the brand has fallen in both stature and profitability. American Eagle owns both its namesake brand and the more affordable Aerie brand, although it doesn't own any of the factories around the world where its clothes are produced. The company sources its goods from a global array of facilities, including 101 factories in China, 67 in Vietnam, 39 in India, 27 in Cambodia, and 24 in Bangladesh. Although the company has other sources in Central America and Europe, most of its suppliers reside in Asia, which presents a problem in the current tariff environment.
<figure class="wp-block-image"><img decoding="async" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXd0BbOecuJufdVxg0kMALPLLqJ9cl3fbjn3XW5xGNZkdzRZaNB48nKT45HsTfmRFHANAFjW8f3PFZtxnRm6DMakRWs-Qj6oaW_oi9p5xA_mnT2nfhCpg24IfxflKoJJoJ1IpEvAuw?key=sXJ17IrwuKIuXW9LDYR8oIXq" alt="" /></figure>
AEO's valuation makes it look tempting to buy, but investors should be cautious due to the company&#8217;s heavy reliance on Asian facilities it does not own. AEO shares trade at just 7.4 times forward earnings with a 0.36 Price-to-Sales (P/S) ratio, but its profit margins are lower than those of competitors like Abercrombie and Fitch and Urban Outfitters. The stock hasn't traded above its 200-day moving average since last October, and it is one of the most heavily shorted apparel retailers, with nearly 19% of its float sold short.
<h2 class="wp-block-heading">Levi Strauss and Co.&nbsp;</h2>
Levi Strauss (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) makes arguably the world's most famous pair of jeans, but unfortunately, those jeans are manufactured in areas facing heavy tariffs. The company's factory list spans a wider geographic range than Columbia or VF Corp, but the Asian presence is heavy, especially in China, Cambodia, and Vietnam. Its only locations in the United States are in Los Angeles. 
<figure class="wp-block-image"><img decoding="async" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXenfA3PMf7c4DJtQFcipbzAYAsKz9Uwm4mG1eIQ8W_1zjRDDzPitwbDGLgWXzQfeJFRKnLm1mWWzHeNcl2t2tq8ICN5wcSukMmHPvIEyiiyVvBQsD9GMQTtpcaV2cRpetdE27Jcrg?key=sXJ17IrwuKIuXW9LDYR8oIXq" alt="" /></figure>
Unlike Columbia or VF Corp, Levi's saw its revenue and margins rebound from the lows of 2024. In February, it posted its first profit margin of over 5% since May 2023, and revenue grew for the third consecutive quarter. However, the company still faces headwinds beyond tariffs, as LEVI shares trade at 11.6 times forward earnings with a high Price-to-Book (P/B) ratio of 3.01. Its dividend payout ratio (DPR) is also over 58%, an elevated figure for an apparel manufacturer. Benzinga Edge is not fond of the stock either, ranking it 25.66 in Momentum and 60.95 in Growth. And finally, the stock is trading firmly below its 50-day and 200-day moving averages, a technical signal pointing to more downside momentum.
<h2 class="wp-block-heading">Matt Maley Alerts Inner Circle Before TV Appearances</h2>
While millions watch Matt discuss tariffs on Bloomberg, CNBC, and more — only his Inner Circle members received his specific trade recommendations. Get Behind the Scenes Access <a href="https://www.benzinga.com/premium/ideas/7-day-free-trial-matt-maley-inner-circle/?el=ResearchDaily&amp;he={{email}}&amp;adt_ei={{email}}&amp;utm_adType=SponsorAd&amp;utm_ad=RD0425&amp;utm_campaign=7daytrial">HERE</a>
Editorial content from our Expert contributors is intended to be information for the general public and not individualized investment advice. Editors/contributors are presenting their individual opinions and strategies, which are neither expressly nor impliedly approved or endorsed by Benzinga.
Photo: Shutterstock

Opinion

Trading Ideas

COLM

LEVI

China Trade War: 4 Big-Brand Stocks That Will Suffer Most

<a href="https://theaircurrent.com/feed/dispatches/boeing-shelves-plans-nasa-x-66-flight-demonstrator-ttbw/#:~:text=Boeing%20will%20%E2%80%9Cpause%E2%80%9D%20development%20of,chief%20technology%20officer%2C%20Todd%20Citron" title="https://theaircurrent.com/feed/dispatches/boeing-shelves-plans-nasa-x-66-flight-demonstrator-ttbw/#:~:text=Boeing%20will%20%E2%80%9Cpause%E2%80%9D%20development%20of,chief%20technology%20officer%2C%20Todd%20Citron">https://theaircurrent.com/feed/dispatches/boeing-shelves-plans-nasa-x-66-flight-demonstrator-ttbw/#:~:text=Boeing%20will%20%E2%80%9Cpause%E2%80%9D%20development%20of,chief%20technology%20officer%2C%20Todd%20Citron</a>.

'Boeing Shelves Plans To Fly NASA X-66 Flight Demonstrator' - The Air Current

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Barclays analyst Gena Wang initiated coverage on Cytokinetics, Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYTK#NASDAQ">CYTK</a>) with an Overweight rating and announced a price target of $5. Cytokinetics shares closed at $38.00 on Wednesday. <a href="https://www.benzinga.com/quote/CYTK/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Lake Street analyst Jacob Stephan initiated coverage on ACCESS Newswire Inc. (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ACCS#AMEX">ACCS</a>) with a Buy rating and announced a price target of $15. ACCESS Newswire shares closed at $8.65 on Wednesday. <a href="https://www.benzinga.com/quote/ACCS/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying CYTK stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="617" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/24130035/image-154-1024x617.png" alt="" class="wp-image-887149" style="width:591px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/24130035/image-154-1024x617.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/24130035/image-154-300x181.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/24130035/image-154-768x463.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/24130035/image-154.png 1115w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/04/44948767/top-2-consumer-stocks-that-may-implode-this-month">Top 2 Consumer Stocks That May Implode This Month</a> </li>
</ul>
Photo via Shutterstock

Initiation

Markets

ACCS

CYTK

This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Thursday

Morgan Stanley analyst Joseph Moore maintains Texas Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) with a Underweight and raises the price target from $146 to $148.

Morgan Stanley Maintains Underweight on Texas Instruments, Raises Price Target to $148

UBS analyst Damian Karas maintains Lennox Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LII#NYSE">LII</a>) with a Neutral and lowers the price target from $625 to $570.

UBS Maintains Neutral on Lennox Intl, Lowers Price Target to $570

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.averydennison.com&amp;esheet=54243409&amp;newsitemid=20250424779365&amp;lan=en-US&amp;anchor=Avery+Dennison+Corporation&amp;index=1&amp;md5=630047b1d00fc1e4f78910b03fe6f2b9">Avery Dennison Corporation</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVY#NYSE">AVY</a>) today announced that its Board of Directors has increased the company's quarterly dividend. The board declared a quarterly dividend of $0.94 per share, representing an increase of approximately 7% over the previous dividend rate. The dividend for the second quarter is payable on June 18, 2025 to shareholders of record as of June 4, 2025.

Dividends

Avery Dennison Increases Quarterly Dividend By 7% To $0.94/Shr

Press Releases

Deep Track Capital Sends Letter to Dynavax Technologies' Board of Directors

Management

BridgeBio Announces CFO Succession

Health Care

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

BridgeBio to Present Cardiovascular Outcomes Data in Patients with Variant and Wild-type Transthyretin Amyloid Cardiomyopathy (ATTR-CM) from the ATTRibute-CM Study at the ACC Annual Scientific Sessions

General

Beyonttra™ (acoramidis), the First Near-complete TTR Stabilizer (≥90%), Approved in Japan to Treat ATTR-CM

Acoramidis Shows Statistically Significant Improvements in Cardiovascular Outcomes in Patients with Variant ATTR-CM

BBOT Announces First Patient Dosed with BBO-11818, a PanKRAS Dual Inhibitor, in the Phase 1 KONQUER-101 Trial for Advanced Solid Tumors

BridgeBio to Host First Quarter 2025 Financial Results Conference Call on Tuesday, April 29, 2025 at 4:30 pm ET

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of BridgeBio Pharma, Inc. (NASDAQ: BBIO)

Comments

BridgeBio Pharma

ニュース

パートナーシップ

ベンジンガ・グローバル